Non-Alcohol Antiseptic Hand Products Should Prove Efficacy - NDAC

摘要

Marketers of non-alcohol-based consumer antiseptic products should be required to prove their products provide clinical benefit prior to sale,an FDA advisory panel unanimously agreed Oct.20.The Nonprescription Drugs Advisory Committee convened in Silver Spring,Md.,to evaluate the efficacy and risks of antiseptic and antibacterial products marketed to consumers.Panel concerns centered on the potential relationship between biocides used in antibacterial products,such as triclosan and triclocarban,and antibiotic resistance.